GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1901 - 1925** of **4050** in total

« First

‹ Prev

…

73

74

75

76

77

78

79

80

81

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	24	mild	G39213VZ	50
IgM	Patient 2	15	mild	G39213VZ	240
IgM	Patient 2	24	mild	G39213VZ	275
IgG	Patient 1	6	moderate	G39213VZ	23
IgM	Patient 1	6	moderate	G39213VZ	33
IgA	Patient 2	3	mild	G39213VZ	699
IgG	Patient 2	3	mild	G39213VZ	67
IgM	Patient 2	3	mild	G39213VZ	408
IgA	Patient 3	-180	mild	G39213VZ	277
IgA	Patient 3	11	mild	G39213VZ	404
IgG	Patient 3	-180	mild	G39213VZ	54
IgM	Patient 3	-180	mild	G39213VZ	104
IgA	Patient 3	4	mild	G39213VZ	420
IgG	Patient 3	11	mild	G39213VZ	36
IgG	Patient 3	4	mild	G39213VZ	33
IgM	Patient 3	11	mild	G39213VZ	106
IgM	Patient 3	4	mild	G39213VZ	98
IgA	Patient 4	12	mild	G39213VZ	397
IgG	Patient 4	12	mild	G39213VZ	57
IgM	Patient 4	12	mild	G39213VZ	112
IgA	Patient 1	10	moderate	G40696TO	394
IgA	Patient 1	22	moderate	G40696TO	366
IgA	Patient 1	6	moderate	G40696TO	359
IgG	Patient 1	10	moderate	G40696TO	23
IgG	Patient 1	22	moderate	G40696TO	26